20-62952880-A-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_022082.4(SLC17A9):​c.50A>C​(p.Gln17Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000011 in 911,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q17R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 0)
Exomes 𝑓: 0.0000011 ( 0 hom. )

Consequence

SLC17A9
NM_022082.4 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.03

Publications

0 publications found
Variant links:
Genes affected
SLC17A9 (HGNC:16192): (solute carrier family 17 member 9) This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
SLC17A9 Gene-Disease associations (from GenCC):
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis 8, disseminated superficial actinic type
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13563788).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC17A9NM_022082.4 linkc.50A>C p.Gln17Pro missense_variant Exon 1 of 13 ENST00000370351.9 NP_071365.4 Q9BYT1-1
SLC17A9XR_936601.4 linkn.172A>C non_coding_transcript_exon_variant Exon 1 of 10
SLC17A9NM_001302643.2 linkc.-31A>C 5_prime_UTR_variant Exon 1 of 14 NP_001289572.2 Q9BYT1-2H0UI90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC17A9ENST00000370351.9 linkc.50A>C p.Gln17Pro missense_variant Exon 1 of 13 1 NM_022082.4 ENSP00000359376.4 Q9BYT1-1
SLC17A9ENST00000370349.7 linkc.-31A>C 5_prime_UTR_variant Exon 1 of 14 1 ENSP00000359374.3 Q9BYT1-2
SLC17A9ENST00000488738.5 linkn.170A>C non_coding_transcript_exon_variant Exon 1 of 11 2
SLC17A9ENST00000411611.1 linkc.-274A>C upstream_gene_variant 2 ENSP00000388215.1 Q5W197

Frequencies

GnomAD3 genomes
Cov.:
0
GnomAD4 exome
AF:
0.00000110
AC:
1
AN:
911934
Hom.:
0
Cov.:
35
AF XY:
0.00
AC XY:
0
AN XY:
446634
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
20066
American (AMR)
AF:
0.00
AC:
0
AN:
22678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12422
East Asian (EAS)
AF:
0.00
AC:
0
AN:
11756
South Asian (SAS)
AF:
0.00
AC:
0
AN:
63344
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12372
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2186
European-Non Finnish (NFE)
AF:
0.00000136
AC:
1
AN:
734234
Other (OTH)
AF:
0.00
AC:
0
AN:
32876
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 01, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.50A>C (p.Q17P) alteration is located in exon 1 (coding exon 1) of the SLC17A9 gene. This alteration results from a A to C substitution at nucleotide position 50, causing the glutamine (Q) at amino acid position 17 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
7.6
DANN
Benign
0.64
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.034
N
LIST_S2
Benign
0.41
T
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L
PhyloP100
-1.0
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.036
Sift
Benign
0.19
T
Sift4G
Benign
0.20
T
Polyphen
0.28
B
Vest4
0.14
MVP
0.076
MPC
0.53
ClinPred
0.082
T
GERP RS
-0.76
PromoterAI
-0.013
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.16
gMVP
0.29
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs560535105; hg19: chr20-61584232; API